Corcept Therapeutics (CORT) Change in Inventory (2012 - 2026)

Corcept Therapeutics has reported Change in Inventory for 15 years, with the latest figure at $4.3 million in Q2 2026.

• Quarterly Change in Inventory fell 7.83% year-over-year to $4.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.0 million (up 264.35% YoY) and the FY2025 annual result came in at $7.5 million, up 2552.79% from the prior year.
• Change in Inventory improved to $4.3 million in Q2 2026 per CORT's latest filing, from $3.3 million in the prior quarter.
• Over five years, Change in Inventory peaked at $4.6 million in Q2 2025 and troughed at -$1.1 million in Q3 2024.
• A 5-year average of $680444.4 and a median of -$227000.0 in 2022 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2025 and 2026: Change in Inventory sank 719.23% in 2025, then jumped 640.83% in 2026.
• Over 5 years, Change in Inventory stood at -$125000.0 in 2022, then tumbled by 163.2% to -$329000.0 in 2023, then soared by 123.71% to $78000.0 in 2024, then tumbled by 719.23% to -$483000.0 in 2025, then surged by 982.82% to $4.3 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $4.3 million, $3.3 million, and -$483000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.